Literature DB >> 10766028

Unordered structured of proinsulin C-peptide in aqueous solution and in the presence of lipid vesicles.

M Henriksson1, J Shafqat, E Liepinsh, M Tally, J Wahren, H Jörnvall, J Johansson.   

Abstract

Proinsulin C-peptide ameliorates renal and autonomic nerve function and increases skeletal muscle blood flow, oxygen uptake and glucose transport in patients with insulin-dependent diabetes mellitus. These effects have in part been ascribed to the stimulatory influence of C-peptide on Na+,K+-ATPase and endothelial nitric oxide synthase. To evaluate the capacity of C-peptide to insert into lipid bilayers and form ion channels, C-peptide secondary structure and membrane interactions were studied with circular dichroism spectroscopy and size exclusion chromatography. C-peptide is shown to lack a stable secondary structure, both when part of proinsulin and when free in aqueous solution, although the N-terminal third of the peptide exhibits an alpha-helical conformation in trifluoroethanol. Moreover, C-peptide remains disordered in the aqueous solvent in the presence of lipid vesicles, regardless of vesicle composition. In conclusion, C-peptide is unlikely to elicit physiological effects through stable conformation-dependent interactions with lipid membranes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10766028     DOI: 10.1007/pl00000695

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  9 in total

1.  Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome.

Authors:  Birger Scholz; Karl Sköld; Kim Kultima; Celine Fernandez; Sofia Waldemarson; Mikhail M Savitski; Marcus Söderquist; Mats Borén; Robert Stella; Per Andrén; Roman Zubarev; Peter James
Journal:  Mol Cell Proteomics       Date:  2010-01-28       Impact factor: 5.911

2.  C-peptide is a bioactive peptide.

Authors:  J Wahren; K Ekberg; H Jörnvall
Journal:  Diabetologia       Date:  2007-01-18       Impact factor: 10.122

3.  C-peptide microheterogeneity in type 2 diabetes populations.

Authors:  Paul E Oran; Jason W Jarvis; Chad R Borges; Randall W Nelson
Journal:  Proteomics Clin Appl       Date:  2009-11-11       Impact factor: 3.494

Review 4.  C-peptide: a new potential in the treatment of diabetic nephropathy.

Authors:  J Wahren; K Ekberg; B Samnegård; B L Johansson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

5.  Proinsulin C-peptide elicits disaggregation of insulin resulting in enhanced physiological insulin effects.

Authors:  J Shafqat; E Melles; K Sigmundsson; B-L Johansson; K Ekberg; G Alvelius; M Henriksson; J Johansson; J Wahren; H Jörnvall
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

6.  Metal-activated C-peptide facilitates glucose clearance and the release of a nitric oxide stimulus via the GLUT1 transporter.

Authors:  J A Meyer; J M Froelich; G E Reid; W K A Karunarathne; D M Spence
Journal:  Diabetologia       Date:  2007-10-27       Impact factor: 10.122

Review 7.  Physiological effects and therapeutic potential of proinsulin C-peptide.

Authors:  Gina L C Yosten; Christine Maric-Bilkan; Patrizia Luppi; John Wahren
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-09-23       Impact factor: 4.310

Review 8.  The clinical potential of C-peptide replacement in type 1 diabetes.

Authors:  John Wahren; Asa Kallas; Anders A F Sima
Journal:  Diabetes       Date:  2012-04       Impact factor: 9.461

9.  pH-Dependent Interaction between C-Peptide and Phospholipid Bicelles.

Authors:  Sofia Unnerståle; Lena Mäler
Journal:  J Biophys       Date:  2012-07-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.